뇌질환의 혁신, 뉴로벤티(NeuroVenti)

NEWS

Here's the news about NeuroVenti

Neuroventi non-clinical CDRO service

페이지 정보

조회 1,450회 작성일 23-09-04

본문

One-stop solution for new drug development related to brain diseases!

[Neuroventi non-clinical CDRO service]


- What is a non-clinical CDRO company?

Non-clinical CDRO is an animal clinical testing agency in the process of developing drugs, food, cosmetics, etc. Refers to an institution that provides up to. Neuroventi is a professional non-clinical CDRO service provider specialized in central nervous system diseases. It has expertise in candidate discovery, mechanism of action identification, effectiveness evaluation, and side effect verification in the field of central nervous system diseases, providing the highest level of comprehensiveness in related development substances in Korea. We can provide consulting and research services.


- Why Neuroventi?

1. Specialized in central nervous system diseases

2. Comprehensive consulting based on unrivaled experience and know-how

3. One-stop system from candidate discovery to optimization

4. Providing Korea’s only side effect verification platform


[Performing new drug consulting work]

- Comprehensive consulting service for new drug development related to brain diseases

1. General pharmacological consulting on the development of brain disease treatments (design consultation, direction setting, result interpretation)

2. New drug development service related to brain diseases: One-stop platform from modeling (in vitro, in vivo) to efficacy search

1) Production and supply of brain disease simulation models

2) Derivation of effective substances through mass drug screening

3. Central nervous system disease side effect profiling


[We promise 5 things]

Our Neuroventi CDRO,

1. Comprehensive consulting: Presenting the best direction based on unrivaled experience and know-how

2. One-stop system: One-stop process from candidate discovery to optimization, efficacy evaluation and mechanism research

3. Optimal solution: Optimal efficacy evaluation system suited to the needs of consumers

4. New target discovery: AI-based mechanism of action and target verification, new target discovery, etc.

5. Side effect profiling: Ensuring drug development safety through side effect evaluation system


[way to come]

- Neuroventi, Room 401, Daebu Building, 15 Seolleung-ro 121-gil, Gangnam-gu, Seoul

T. 02-540-5630

F. 02-548-5630

E. contact@neuroventi.com


- To apply for CDRO, click the link below!

http://www.neuroventi.com/bbs/write.php?bo_table=online


#neuroventi #neuroventi #cro #cdro #preclinical #nonclinical #nonclinical trial